Inventor
CHU DANIEL T
US56 patents
⚠️ This page may combine multiple inventors who share the name “CHU DANIEL T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBOTT LAB
49 patentsUS5866549AFeb 2, 1999
6-O-substituted ketolides having antibacterial activity
ABBOTT LAB176 citations99
US5922683AJul 13, 1999
Multicyclic erythromycin derivatives
ABBOTT LAB101 citations97
US6124269ASep 26, 2000
2-Halo-6-O-substituted ketolide derivatives
ABBOTT LAB97 citations96
US6075133AJun 13, 2000
6-O-substituted antibacterial erythromycin ketolides and methods of making
ABBOTT LAB43 citations96
US5580872ADec 3, 1996
Quinolizinone type compounds
ABBOTT LAB60 citations96
US5137892AAug 11, 1992
Quinoline, naphthyridine and pyridobenzoxazine derivatives
ABBOTT LAB73 citations96
US4730000AMar 8, 1988
Quinoline antibacterial compounds
ABBOTT LAB77 citations96
US4762845AAug 9, 1988
7-(3-Substituted imino-1-pyrrolidinyl)-quinolone-3-carboxylic acids
ABBOTT LAB65 citations95
US6034069AMar 7, 2000
3-'N-modified 6-O-substituted erythromycin ketolide derivatives having antibacterial activity
ABBOTT LAB28 citations93
US5780605AJul 14, 1998
6,9-bridged erythromycin derivatives
ABBOTT LAB37 citations93
US5703244ADec 30, 1997
Process for preparation of chiral 3-amino-pyrrolidine and analogous bicyclic compounds
ABBOTT LAB53 citations93
US4994599AFeb 19, 1991
Intermediates for producing quinolone-3-carboxylic acids
ABBOTT LAB22 citations93
US4767762AAug 30, 1988
Tricyclic quinoline and naphthyride antibacterials
ABBOTT LAB30 citations93
US6075011AJun 13, 2000
6-O-substituted erythromycin compounds and method for making same
ABBOTT LAB30 citations92
US6046171AApr 4, 2000
6,11-bridged erythromycin derivatives
ABBOTT LAB56 citations92
US6028181AFeb 22, 2000
6-0-Substituted antibacterial erythromycin ketolides and methods of making
ABBOTT LAB36 citations92
US5750510AMay 12, 1998
3-descladinose-2,3-anhydroerythromycin derivatives
ABBOTT LAB32 citations92
US5624924AApr 29, 1997
Quinobenzothiazine antineoplastic agents
ABBOTT LAB32 citations92
US5599816AFeb 4, 1997
Quinolizinone type compounds
ABBOTT LAB41 citations92
US5318965AJun 7, 1994
Quinobenzoxazine, antineoplastic agents
ABBOTT LAB30 citations92
US4880814ANov 14, 1989
7-cycloalkyl naphthyridines
ABBOTT LAB33 citations92
US4777253AOct 11, 1988
Process for preparation of racemate and optically active ofloxacin and related derivatives
ABBOTT LAB36 citations92
US6274715B1Aug 14, 2001
Tricyclic erythromycin derivatives
ABBOTT LAB54 citations91
US5618813AApr 8, 1997
Benzo[5.6]pyrano[2.3.4-ij]quinolizine and benzo[5.6]thiopyrano[2.3.4-ij]quinolizine derivatives as antibacterial and antineoplastic agents
ABBOTT LAB27 citations89
US4607032AAug 19, 1986
Quino-benoxazine antibacterial compounds
ABBOTT LAB22 citations82
US4533663AAug 6, 1985
Quino-benzothiazine antibacterial compounds
ABBOTT LAB25 citations82
US5780604AJul 14, 1998
11,12-cyclic phosphite or phosphate derivatives of erythromycin and related macrolides
ABBOTT LAB10 citations74
US5668164ASep 16, 1997
Process for synthesis of chiral cis-and trans-3-amino-4 substituted pyrrolidine compounds
ABBOTT LAB6 citations74
US5618949AApr 8, 1997
Process for synthesis of chiral cis- and trans-3-amino-4-substituted pyrrolidine compounds
ABBOTT LAB9 citations74
US5252747AOct 12, 1993
Chiral quinolone intermediates
ABBOTT LAB7 citations74
US4962112AOct 9, 1990
7-(2-methyl-4-aminopyrrolidinyl)naphthryidine and quinoline compounds
ABBOTT LAB6 citations74
US4774246ASep 27, 1988
Quinoline antibacterial compounds
ABBOTT LAB13 citations74
US4689325AAug 25, 1987
Isoxazolo-pyrido-phenoxazine and isothiazolo-pyrido-phenoxazine derivatives
ABBOTT LAB10 citations74
US4687770AAug 18, 1987
Isoxazolo-pyrido-benzoxazine and isothiazolo-pyrido-benzoxazine derivatives
ABBOTT LAB7 citations74
US4616019AOct 7, 1986
Naphthyridine antibacterial compounds
ABBOTT LAB18 citations74
US4542133ASep 17, 1985
Methylenedioxy quino-benoxazine derivatives and antibacterial use
ABBOTT LAB10 citations74
US4540694ASep 10, 1985
1-Pyridine substituted quino-benoxazines and antibacterial use
ABBOTT LAB14 citations74
US4529725AJul 16, 1985
1-Pyridine substituted quino-benzothiazine
ABBOTT LAB7 citations74
US4528285AJul 9, 1985
Methylenedioxy quino-benzothiazine derivatives
ABBOTT LAB9 citations74
US4347355AAug 31, 1982
Inhibitors of transpeptidase
ABBOTT LAB11 citations74
US5747466AMay 5, 1998
3-deoxy-3-descladinose derivatives of erythromycins A and B
ABBOTT LAB9 citations73
US5726182AMar 10, 1998
Quinolizinone type compounds
ABBOTT LAB12 citations73
US5057520AOct 15, 1991
7-(peptidylpyrolidinyl)naphthyridine antibacterial compounds
ABBOTT LAB18 citations73
US4826985AMay 2, 1989
Intermediates for preparation of racemate and optically active ofloxacin and related derivatives
ABBOTT LAB6 citations73
US5789591AAug 4, 1998
Process for preparing 1-substituted 8-chloro-7-fluoro-9-methyl-4-oxo-4H-quinolizine-3-carboxylic acid ethyl ester compounds
ABBOTT LAB9 citations69
USRE39591EApr 24, 2007
6-O-substituted ketolides having antibacterial activity
ABBOTT LAB2 citations63
US4859776AAug 22, 1989
(S)-7-(3-aminopyrrolidin-1-yl)-1-(ortho, para-difluorophenyl)-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid and method for its preparation
ABBOTT LAB5 citations63
US4397784AAug 9, 1983
Inhibitors of transpeptidase
ABBOTT LAB2 citations63
US5057523AOct 15, 1991
Dipeptide quinolone derivatives
ABBOTT LAB5 citations62
(unassigned)
1 patentShowing the top 50 of 56 patents by PatentIndex Score.